Fondazione IRCCS Istituto Nazionale Tumori
Fondazione IRCCS Istituto Nazionale Tumori
Milan, MI, Italy2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. | Colorectal Cancer Metastatic | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-20 | NCT04564898 | |
| Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; Stage IA1 Endometrial Cancer FIGO 2023; Stage IA2 Endometrial Cancer FIGO 2023 | Recruiting | Not stated | 2026-02-19 | NCT06689956 |